Status:
COMPLETED
Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Olympus
Conditions:
Lung Neoplasms
Esophageal Lesion
Eligibility:
All Genders
Phase:
PHASE1
PHASE2
Brief Summary
This will be a prospective, (NSR), single-center feasibility study of the Olympus VE2 NIR Imaging System to assess perfusion using NIR during minimally invasive esophagectomy and pulmonary segmentecto...
Detailed Description
Current Surgical Approaches to Thoracic Malignancies are Imperfect: Thoracic malignancies are among the most deadly cancers diagnosed across the world. Non-small cell lung cancer (NSCLC) remains the n...
Eligibility Criteria
Inclusion
- Subject has a suspicious lung lesion for which a minimally invasive segmentectomy is planned -OR- sub-ject has an esophageal lesion for which an esophagectomy is planned -
- Subject is 18 years of age or older
- Subject is willing and able to provide informed consent
Exclusion
- Subject is not eligible for surgical resection as determined by the treating physician
- Subject has known or suspected allergy to Iodine, shellfish or intravenous contrast
- Subject is not eligible or considered high risk for surgical resection as determined by pre-operative spirometry
- Subject is female and of childbearing age who is currently pregnant or who is planning to become pregnant within the study
- Subject is unable and unwilling to provide informed consent
- Subject has liver disease or is taking drugs impact liver metabolism.
Key Trial Info
Start Date :
October 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 3 2025
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05346380
Start Date
October 29 2020
End Date
June 3 2025
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114